Last reviewed · How we verify
NCT03193892
A National Registry on Chinese Patients With Lymphangioleiomyomatosis
trial in Pulmonary Function in 1,500 participants. Currently enrolling.
1 October 2026
Quick facts
| Lead sponsor | Peking Union Medical College Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 1,500 |
| Start date | 1 January 2017 |
| Primary completion | 1 October 2026 |
| Estimated completion | 1 October 2026 |
| Sites | 1 location across China |
Conditions studied
- Pulmonary Function — all drugs for Pulmonary Function →
Sponsor
Peking Union Medical College Hospital
Who can join
Eligibility, female only, with Pulmonary Function. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pulmonary lymphangioleiomyomatosis (LAM), a disease characterized by diffuse cystic changes in the lung, is a rare disorder that affects almost exclusively women. The main objectives of this study are to accurately evaluate the prevalence of LAM, the status of disease, the diagnosis and treatment, the quality of care, and the health related outcomes in China.
Publications & conference data
5 peer-reviewed publications reference this trial (live from Europe PMC):
-
Determinants of Progression and Mortality in Lymphangioleiomyomatosis.
Xu W, Yang C, Cheng C, Wang Y, et al · · 2023 · cited 24× · PMID 36801466 · DOI 10.1016/j.chest.2023.02.026 -
Long-term safety and influence on growth in patients receiving sirolimus: a pooled analysis.
Wang YY, Zou LP, Xu KF, Xu WS, et al · · 2024 · cited 5× · PMID 39148107 · DOI 10.1186/s13023-024-03243-5 -
Increased malignancy risk in patients with lymphangioleiomyomatosis: findings from a Chinese cohort.
Zhang X, Cheng C, Wang H, Liu J, et al · · 2025 · cited 1× · PMID 40450294 · DOI 10.1186/s13023-025-03834-w -
Associations of VEGF-D levels with clinical manifestations in lymphangioleiomyomatosis: a cross-sectional analysis of 631 cases.
Yang L, Wang H, Cheng C, Zhang M, et al · · 2025 · cited 1× · PMID 40420164 · DOI 10.1186/s13023-025-03802-4 -
Six-minute walk distance predicting the risk of mortality in lymphangioleiomyomatosis patients.
Yang L, Zhang X, Wang L, Cheng C, et al · · 2026 · PMID 41514454 · DOI 10.1186/s13023-026-04194-9
Verify or expand the search:
- PubMed search for NCT03193892
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pulmonary Function
Currently open trials in the same condition.
- NCT07380789 — Comprehensive Multicenter Study on the Management of Acute Pain Following Thoracic Combat-Related Trauma in Ukraine · NA · recruiting
- NCT07196436 — Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study · NA · recruiting
- NCT06961838 — The Effect of Inspiratory Muscle Training With Substance Use Disorder · NA · recruiting
- NCT07112703 — Effect of Incentive Respiratory Training on Pulmonary Functions and Functional Capacity in Children With B-thalassemia M · NA · recruiting
- NCT06477458 — Deep Learning for Preoperative Pulmonary Assessment in Thoracic CT · recruiting
Other Peking Union Medical College Hospital trials
Trials by the same sponsor.
- NCT07466251 — PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke · Phase 4 · not yet recruiting
- NCT06743321 — Speech-to-speech Voice-cloning Care (SVCC) to Improve ICU-acquired Anxiety for Critically Ill Patients · NA · not yet recruiting
- NCT07590336 — 68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma · Phase 1, PHASE2 · not yet recruiting
- NCT07515976 — Mapping of Genomic Structural Variations in Major Birth Defects · not yet recruiting
- NCT07386756 — Early Precise Identification and Intervention Strategies for Individuals at High Risk of Prediabetes · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03193892 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peking Union Medical College Hospital
- Last refreshed: 24 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03193892.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing